Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade
NCT ID: NCT00233467
Last Updated: 2017-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2005-09-01
2005-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years
NCT00230893
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581
Enhancing the Prospective Prediction of Psychosis
NCT00291200
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
NCT00932529
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study
NCT05872555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data will be retrieved from a computerized list of patients treated at the TVAMC for PTSD from 1994-2004 Charts will be reviewed by looking at approximately ten year's worth of data. Charts will then be examined to determine what type of antipsychotics patients were prescribed, the dose and duration of the antipsychotics, and the presence or absence of documented psychotic symptoms.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male or female patients at least 19 years of age
Exclusion Criteria
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tuscaloosa Research & Education Advancement Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lori Davis, MD
ACSO for Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca Seamans, PharmD
Role: PRINCIPAL_INVESTIGATOR
Tuscaloosa Veterans Affairs Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tuscaloosa VA Medical Center
Tuscaloosa, Alabama, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kozaric-Kovacic D, Pivac N, Muck-Seler D, Rothbaum BO. Risperidone in psychotic combat-related posttraumatic stress disorder: an open trial. J Clin Psychiatry. 2005 Jul;66(7):922-7. doi: 10.4088/jcp.v66n0716.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TREAC Retro PTSD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.